Down Regulation of the Expression of ELMO3 by COX2 Inhibitor Suppresses Tumor Growth and Metastasis in Non-Small-Cell Lung Cancer

Down Regulation of the Expression of ELMO3 by COX2 Inhibitor Suppresses Tumor Growth and Metastasis in Non-Small-Cell Lung Cancer

Non-small cell lung cancer (NSCLC) is one of the most common malignancies. Studies have shown that engulfment and cell motility 3 (ELMO3) is highly expressed in NSCLC and can be used as a novel biomarker, but its underlying mechanism remains to be explored. The aim of this study was to investigate t...

Full description

Bibliographic Details
Main Authors: Cailong Pan, Yong Zhang, Qinghai Meng, Guoliang Dai, Zhitao Jiang, Hongguang Bao
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-05-01
Series:Frontiers in Oncology
Subjects:
ELMO3
COX-2
EMT
NSCLC
ParecoxibNa
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2019.00363/full

Similar Items

Similar Items